Masaki Maezawa1, Ken-Ichi Watanabe2, Kotaro Matsumoto2, Yoshiyasu Kobayashi2, Haruko Ogawa2, Hisashi Inokuma1. 1. Veterinary Medical Center, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-8657, Japan. 2. Department of Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido 080-8555, Japan.
Abstract
Enzootic bovine leukosis (EBL) is typically observed in cattle over 3 years old. However, some cases of EBL onset in young beef cattle have been reported in Japan. The mechanism for early EBL onset is unclear. In Japan, beef cattle are given large amounts of concentrated feed with low vitamin A. Bone morphogenetic proteins (BMPs) are regulators of cell proliferation, differentiation, and apoptosis, and thought to represent one of the key players in tumor malignancy. The purpose of this study was to evaluate the differences in BMP-6 methylation status between EBL beef cattle under 3 years old and other cattle. We investigated the methylation status of the BMP-6 promoter region in 32 EBL beef cattle under 3 years old. We also compared the methylation status of EBL dairy cattle to that of healthy cattle. Median methylation rate of the BMP-6 promoter region in EBL beef cattle under 3 years old was 8.9%, which was significantly higher than that of other groups. Hypermethylation of the BMP-6 promoter region might contribute to early onset of EBL in beef cattle under 3 years old, and animal feeding management practices specific to beef cattle may affect the methylation status of the BMP-6 promoter region.
Enzootic bovine leukosis (EBL) is typically observed in cattle over 3 years old. However, some cases of EBL onset in young beef cattle have been reported in Japan. The mechanism for early EBL onset is unclear. In Japan, beef cattle are given large amounts of concentrated feed with low vitamin A. Bone morphogenetic proteins (BMPs) are regulators of cell proliferation, differentiation, and apoptosis, and thought to represent one of the key players in tumor malignancy. The purpose of this study was to evaluate the differences in BMP-6 methylation status between EBL beef cattle under 3 years old and other cattle. We investigated the methylation status of the BMP-6 promoter region in 32 EBL beef cattle under 3 years old. We also compared the methylation status of EBL dairy cattle to that of healthy cattle. Median methylation rate of the BMP-6 promoter region in EBL beef cattle under 3 years old was 8.9%, which was significantly higher than that of other groups. Hypermethylation of the BMP-6 promoter region might contribute to early onset of EBL in beef cattle under 3 years old, and animal feeding management practices specific to beef cattle may affect the methylation status of the BMP-6 promoter region.
Entities:
Keywords:
CpG islands; beef cattle; bone morphogenetic protein 6; early onset; enzootic bovine leucosis; methylation
Enzootic bovine leukosis (EBL) is one of the most common neoplasms in cattle and is caused by
bovine leukemia virus (BLV) [38]. BLV-infectedcattle
usually remain clinically silent without symptoms, and less than 5% of the infected animals
develop EBL [10]. Because BLV requires a long latency
period, median incubation period of EBL were estimated to be 7 years and EBL is typically
observed in cattle over 3 years old [10, 42]. However, early onset of EBL in cattle under 3 years
old has also been reported [25, 26, 33, 34], and the incidence of EBL onset in young beef cattle has increased in
Japan [39]. Several factors relating to the progression
of EBL from an asymptomatic state have been reported [22, 24]. Tax mutations and integration site
of the BLV provirus are thought to influence the early onset of EBL [17, 25]. Moreover, intrauterine
infection of BLV has been reported [37] and the
incubation period may begin in the fetal period. However, detailed mechanisms for this remain
unclear.Epigenetic modifications including DNA methylation can alter the transcription and
translation of particular genes to increase or decrease their functional levels in mammals
[3]. Gene silencing caused by epigenetic modification
is an important mechanism of inhibition of tumor suppressor gene expression in various cancers
[15, 44]. DNA
methylation refers to the addition of methyl groups to CpG dinucleotides in DNA [18, 32] and usually
occurs in CpG islands with a high density of CpG dinucleotides [7]. Hypermethylation-associated gene silencing of tumor suppression, cell adhesion,
and apoptosis has been described in malignant lymphoma cases in dogs, cats, and humans [6, 8, 9, 11, 12, 29]. Therefore,
changes in methylation patterns are thought to be important for lymphomagenesis.Bone morphogenetic proteins (BMPs), belonging to the transforming growth factor-β
superfamily, are important regulators of cell proliferation, differentiation, and apoptosis
[4]. In B-cells, BMP-6 reduces proliferation and
induces apoptosis [21]. Moreover, repression of BMP-6
by methylation were found in humanlymphoma [6, 41]. Therefore, inactivation of BMP-6 is thought to be a
key player of tumorigenesis and progression in humanlymphoma [6, 41]. However, little is known about the
role of BMP-6 with regard to EBL onset.Accordingly, we hypothesized that repression of BMP-6 by methylation contributes to the onset
of EBL in cattle. Moreover, we focused on methylation status of young beef cattle because
methylation status was influenced by diet [36]. In the
present study, we first compared the methylation status of the BMP-6 gene promoter region in
EBL cattle to that of healthy cattle. Next, the methylation status of the BMP-6 gene promoter
region in EBL beef cattle under 3 years old was compared with those of EBL dairy cattle and
healthy cattle. Finally, we analyzed the association between methylation rates of the BMP-6
gene promoter region and BMP-6 gene expression.
MATERIALS AND METHODS
Samples and preparation of DNA
This study was approved by Obihiro University of Agriculture and Veterinary Medicine
Committee for Experiments Using Animals (Approval number: 19-144) based on the Fundamental
Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic
Research Institutions. Samples from 117 cattle were provided by local veterinarians and
meat hygiene inspection centers in Iwate and Hokkaido prefectures, Japan (Supplementary Tables 1–6). Samples comprised peripheral blood,
neoplastic lymph nodes (mediastinal, superficial, mesenteric, subiliac, medial, or iliac
lymph nodes) and tumor tissue (spleen, heart, lung, abomasum, liver, kidney, or uterus)
from 67 EBL cattle (32 EBL beef cattle under 3 years old, 10 EBL dairy cattle under 3
years old, and 25 EBL dairy cattle over 3 years old). Peripheral blood and normal
mesenteric lymph nodes from 50 healthy cattle (20 healthy beef cattle under 3 years old,
15 healthy dairy cattle under 3 years old, and 15 healthy dairy cattle over 3 years old)
were also used. Beef cattle over 3 years old were not included in this study because most
are slaughtered by 3 years old in Japan. The included breeds were Holstein-Frisian (HF,
n=7), Japanese Black (JB, n=11) and crossbreeds of HF and JB (F1, n=14) in EBL beef cattle
under 3 years old, and HF (n=9), JB (n=5), and F1 (n=6) in healthy beef cattle. All dairy
cattle were HF. Production stages of 30 EBL beef cattle and 20 healthy beef cattle were
fatting stage, and those of 2 EBL beef cattle were growing stage. Genomic DNA was
extracted from each sample using QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany) and stored
at −30°C until analysis. EBL cattle were definitively diagnosed by macroscopic and/or
histopathological examination at the Obihiro University of Agriculture and Veterinary
Medicine, Hokkaido, Japan, and monoclonal integration of the BLV provirus was confirmed
using inverse polymerase chain reaction (PCR) [30].
BLV infection in healthy cattle was confirmed by nested PCR for BLV 5′ LTR [26].
Fig. 1.
Representative results in determining the bone morphogenetic protein 6 gene
promoter hypermethylation in enzootic bovine leukosis (EBL) cattle but do not
represent the methylation status of the EBL group. Ten clones were sequenced to
obtain a representative sampling of methylation status. Fifty-six CpG sites in each
sample were analyzed and numbered from left to right. In this case, 498 of 560 CpG
sites were methylated (methylation rate, 88.9%). Methylated and unmethylated sites
are shown by closed and open circles, respectively.
Bisulfite sequencing semi-nested PCR
Sodium bisulfite modification of isolated genomic DNA (1 µg) was performed using the
MethylEasy Xceed Rapid DNA Bisulphite Modification Kit according to the manufacturer’s
instructions (Takara Bio, Kusatsu, Japan). The bisulfite treatment of DNA converts
unmethylated CpG sites to UpG without modifying methlylated sites. Semi-nested PCR on
bisulfite-treated DNA samples for CpG islands in the BMP-6 gene promoter region was
performed with the following primers: F1/R2 (F1: 5′-AGGGGTAAGGGGAAATTT-3′, R2:
5′-CCTCCCCATTAACAAC-3′) for outer PCR and F1/R1 (R1: 5′-TCCCTCCCATCCCTTCTA-3′) for inner
PCR, which yields a PCR product of 485 base pairs (bp). These primers were designed based
on the sequence of CpG islands located in the BMP-6 gene promoter region. TaKaRa EpiTaq™
HS (for bisulfite-treated DNA) (Takara Bio) was used for the PCR. The first amplification
program was carried out as follows: 40 cycles of denaturation at 98°C for 10 sec,
annealing at 55°C for 30 sec, and extension at 72°C for 30 sec. The second PCR was
performed with the same protocol, except that the annealing temperature was set at 53°C.
The PCR products from each sample were electrophoresed in 2% agarose gel and purified from
the gels using QIAquick Gel Extraction Kit (QIAGEN). Purified PCR products were cloned
into the pCRTM4-TOPO vector (Invitrogen, Carlsbad, CA, USA), and transformed into One
Shot® TOP10 Chemically Competent Escherichia coli. Plasmid
DNA from the isolated bacterial clones containing the insert was purified using the
NucleoSpin Plasmid EasyPure (Takara Bio). Plasmid DNA samples from 10 independent clones
for each sample were sequenced with the M13R primer. The DNA sequence was determined with
ABI PRISM BigDye Terminator v3.1 Cycle Sequencing Kits (Applied Biosystems, Norwalk, CT,
USA) and ABI PRISM 3500 Genetic Analyzer (Applied Biosystems) following the manufacturer’s
instructions. Fifty-six CpG sites of 10 clones in each sample were analyzed. Therefore,
methylation rates were determined by the rate of methylated cytosines in 560 CpG
sites.
Reverse transcription-PCR (RT-PCR) of the BMP-6 gene transcript
Neoplastic lymph nodes from 17 EBL cattle were collected in RNAlaterTM Stabilization
Solution (Invitrogen), peripheral blood was collected from 10 healthy cattle in PAXgeneTM
tubes (PreAnalytiX®, Hornbrechtikon, Switzerland), and both samples were
collected from 3 EBL cattle in same methods. These samples were incubated overnight at
room temperature and then at −80°C until analysis. Total RNA was extracted from neoplastic
lymph nodes using the RNeasy Mini Kit (QIAGEN) and from peripheral blood using the
PAXgeneTM Blood RNA Kit (QIAGEN) according to the manufacturer’s instructions. cDNA was
synthesized using 2 µg total RNA and the SuperScriptTM III First-Strand Synthesis System
(Invitrogen). PCR for messenger RNA (mRNA) of BMP-6 gene was performed using GoTaq Master
Mix (Promega, Madison, WI, USA) with the following primer set: 5′-AGGACAGCGCCTTTCTCAAC-3′
and 5′-TTGTAGATTCGGAACTCTGCAGCC-3′, yielding a PCR product of 167 bp. These primers were
designed based on the sequence of BMP-6 gene exons 1 and 2. The amplification program was
carried out as follows: initial incubation at 94°C for 2 min, followed by 35 cycles of
denaturation at 94°C for 30 sec, annealing at 55°C for 30 sec, and extension at 72°C for 1
min, and a final extension at 72°C for 7 min. PCR products were electrophoresed in 2%
agarose gel. RPS15A was used as a control for cDNA integrity and quality [14].
Statistical analyses
The Mann-Whitney U test was used to compare methylation rates of the
BMP-6 gene promoter region between EBL cattle and healthy cattle, and between BLV-positive
healthy cattle and BLV-negative healthy cattle. Methylation rates of the BMP-6 gene
promoter region were statistically analyzed by using the Steel-Dwass and Kruskal-Wallis
tests in 6 groups (EBL beef cattle under 3 years old, EBL dairy cattle under 3 years old,
EBL dairy cattle over 3 years old, healthy beef cattle under 3 years old, healthy dairy
cattle under 3 years old, and healthy dairy cattle over 3 years old). Moreover, median
methylation rates of the BMP-6 gene promoter region in BLV-positive healthy cattle under 3
years old, BLV-positive healthy cattle over 3 years old, BLV-negative healthy cattle under
3 years old and BLV-negative healthy cattle over 3 years old were statistically analyzed
by using Kruskal-Wallis tests. A P-value <0.05 was considered
statistically significant. All statistical analyses were performed with EZR, a graphical
user interface for R (The R Foundation for Statistical Computing, version 1.40) [20].
RESULTS
Methylation status of the BMP-6 gene promoter region in EBL and healthy
cattle
Figure 1 shows the rates of hypermethylation in the BMP-6 gene promoter region in EBL cattle
but do not represent the methylation status of the EBL group. We found that 498 out of 560
CpG sites were methylated (88.9% methylation rate). Methylation rates of the BMP-6 gene
promoter region in EBL and healthy cattle are summarized in Fig. 2. Median methylation rates of the BMP-6 gene promoter region in EBL and healthy
cattle were 5.4% (0.0–88.9%) and 1.8% (0.0–14.8%), respectively. Methylation rates of the
BMP-6 gene promoter region in EBL cattle were significantly higher than those in healthy
cattle (P<0.01 by Mann-Whitney U test).
Fig. 2.
Bone morphogenetic protein 6 gene promoter region methylation rates in enzootic
bovine leukosis (EBL) cattle (black circles, n=67) and healthy cattle (white
circles, n=50). ** indicates a significant difference (P<0.01 by
Mann-Whitney U test). Bars represent the median.
Representative results in determining the bone morphogenetic protein 6 gene
promoter hypermethylation in enzootic bovine leukosis (EBL) cattle but do not
represent the methylation status of the EBL group. Ten clones were sequenced to
obtain a representative sampling of methylation status. Fifty-six CpG sites in each
sample were analyzed and numbered from left to right. In this case, 498 of 560 CpG
sites were methylated (methylation rate, 88.9%). Methylated and unmethylated sites
are shown by closed and open circles, respectively.Bone morphogenetic protein 6 gene promoter region methylation rates in enzootic
bovine leukosis (EBL) cattle (black circles, n=67) and healthy cattle (white
circles, n=50). ** indicates a significant difference (P<0.01 by
Mann-Whitney U test). Bars represent the median.
Comparison of methylation rates of the BMP-6 gene promoter region between EBL beef
cattle under 3 years old and other cattle
Median methylation rates of the BMP-6 gene promoter region in EBL beef cattle under 3
years old, EBL dairy cattle under 3 years old, EBL dairy cattle over 3 years old, healthy
beef cattle under 3 years old, healthy dairy cattle under 3 years old, and healthy dairy
cattle over 3 years old were 8.9% (2.3–88.9%), 3.2% (0.0–9.5%), 2.5% (0.0–46.8%), 2.7%
(0.0–9.5%), 0.7% (0.0–3.1%), and 2.1% (0.0–14.8%), respectively (Fig. 3). Kruskal-Wallis test indicated significant difference of median methylation rates
within the 6 groups (P<0.01), and median methylation rates of the
BMP-6 gene promoter region in EBL beef cattle under 3 years old were significantly higher
than those in the other 5 groups (P<0.05 by Steel-Dwass test) (Fig. 3). Moreover, methylation rates of the BMP-6
gene promoter region in EBL dairy cattle under 3 years old, EBL dairy cattle over 3 years
old, and healthy beef cattle under 3 years old were significantly higher than those in
healthy dairy cattle under 3 years old (P<0.05 by Steel-Dwass test)
(Fig. 3).
Fig. 3.
Bone morphogenetic protein 6 gene promoter region methylation rates in enzootic
bovine leukosis (EBL) beef cattle under 3 years old (black circles, n=32), EBL dairy
cattle under 3 years old (black squares, n=10), EBL dairy cattle over 3 years old
(black triangles, n=25), healthy beef cattle under 3 years old (white circles,
n=20), healthy dairy cattle under 3 years old (white squares, n=15), and healthy
dairy cattle over 3 years old (white triangles, n=15). * and ** indicate a
significant difference (*: P<0.05, **:
P<0.01 by Steel-Dwass test). Bars represent the median.
Bone morphogenetic protein 6 gene promoter region methylation rates in enzootic
bovine leukosis (EBL) beef cattle under 3 years old (black circles, n=32), EBL dairy
cattle under 3 years old (black squares, n=10), EBL dairy cattle over 3 years old
(black triangles, n=25), healthy beef cattle under 3 years old (white circles,
n=20), healthy dairy cattle under 3 years old (white squares, n=15), and healthy
dairy cattle over 3 years old (white triangles, n=15). * and ** indicate a
significant difference (*: P<0.05, **:
P<0.01 by Steel-Dwass test). Bars represent the median.
Methylation rates of the BMP-6 gene promoter region in healthy cattle with and
without BLV infection
BLV infection was detected in 25 of 50 healthy cattle. Median methylation rates of the
BMP-6 gene promoter region were 1.8% (0.0–9.5%) in BLV-positive healthy cattle and 1.5%
(0.0–14.8%) in BLV-negative healthy cattle, showing no significant difference
(P=0.362 by Mann-Whitney U test). Moreover, median methylation rates of
the BMP-6 gene promoter region in BLV-positive healthy cattle under 3 years old,
BLV-positive healthy cattle over 3 years old, BLV-negative healthy cattle under 3 years
old and BLV-negative healthy cattle over 3 years old were 1.8% (0.0–9.5%), 0.9%
(0.0–5.4%), 1.4% (0.0–6.4%) and 2.1% (0.0–14.8%), respectively, suggesting no significant
difference within those 4 groups (P=0.845 by Kruskal-Wallis test).
Association between methylation rates of the BMP-6 gene promoter region and
transcriptional gene silencing
Results of RT-PCR of the BMP-6 gene of 20 EBL and 10 healthy cattle are shown in Fig. 4 and Table 1. The range of methylation rates of the BMP-6 gene promoter region in those
cattle was 0.0–88.6%. Expression of BMP-6 gene mRNA was found in samples with methylation
rates under 9.5%, but not in samples with those over 33.4% (Table 1). All samples expressed the housekeeping gene of RPS15A
mRNA transcripts (Fig. 4 and Table 1).
Fig. 4.
Representative results of reverse transcription-polymerase chain reaction of bone
morphogenetic protein 6 (BMP-6) gene (167 bp) for lymph nodes and peripheral blood
samples in enzootic bovine leukosis (EBL) and healthy cattle. The range of
methylation rates of the BMP-6 gene promoter region in those cattle was 0.0–88.6%.
RPS15A was used as a control for cDNA integrity and quality. M and DW denote
molecular weight marker and distilled water, respectively.
Table 1.
Bone morphogenetic protein 6 (BMP-6) promoter methylation status and BMP-6
expression in enzootic bovine leukosis (EBL) and healthy cattle
Cattle No.
Sample
Methylation rate (%)
Expression
BMP-6
RPS15A
EBL-1
Lymph node
88.6
-
+
EBL-2
Lymph node
83.6
-
+
EBL-3
Peripheral blood
42.9
-
+
Lymph node
45.7
-
+
EBL-4
Lymph node
39.3
-
+
EBL-5
Lymph node
33.4
-
+
EBL-6
Lymph node
7.9
+
+
EBL-7
Peripheral blood
5.2
+
+
Lymph node
5.4
+
+
EBL-8
Peripheral blood
3.8
+
+
Lymph node
3.1
+
+
EBL-9
Lymph node
2.7
+
+
EBL-10
Lymph node
1.8
+
+
EBL-11
Lymph node
9.5
+
+
EBL-12
Lymph node
46.8
-
+
EBL-13
Lymph node
5.5
+
+
EBL-14
Lymph node
3.6
+
+
EBL-15
Lymph node
3.2
+
+
EBL-16
Lymph node
2.7
+
+
EBL-17
Lymph node
2.3
+
+
EBL-18
Lymph node
1.8
+
+
EBL-19
Lymph node
1.1
+
+
EBL-20
Lymph node
0.0
+
+
Healthy-1
Peripheral blood
5.4
+
+
Healthy-2
Peripheral blood
3.1
+
+
Healthy-3
Peripheral blood
1.8
+
+
Healthy-4
Peripheral blood
0.7
+
+
Healthy-5
Peripheral blood
0.0
+
+
Healthy-6
Peripheral blood
5.5
+
+
Healthy-7
Peripheral blood
3.2
+
+
Healthy-8
Peripheral blood
2.1
+
+
Healthy-9
Peripheral blood
0.7
+
+
Healthy-10
Peripheral blood
0.0
+
+
+: Expression was detected by RT-PCR. -: Expression was not detected by RT-PCR.
Representative results of reverse transcription-polymerase chain reaction of bone
morphogenetic protein 6 (BMP-6) gene (167 bp) for lymph nodes and peripheral blood
samples in enzootic bovine leukosis (EBL) and healthy cattle. The range of
methylation rates of the BMP-6 gene promoter region in those cattle was 0.0–88.6%.
RPS15A was used as a control for cDNA integrity and quality. M and DW denote
molecular weight marker and distilled water, respectively.+: Expression was detected by RT-PCR. -: Expression was not detected by RT-PCR.
DISCUSSION
EBL cattle show monoclonal expansion of B cells with identical BLV proviral integration
sites, whereas other BLV-infectedcattle show diverse integration sites [28]. Thus, EBL is strongly suspected by detection of BLV
provirus monoclonal integration in cattle with B-cell lymphoma [34]. EBL is typically observed in cattle over 3 years old [10], and detection of monoclonal integration of BLV
provirus was a useful method for diagnosing EBL in cattle with difficult diagnosis, such as
young cattle [34]. Accordingly, in the present study,
we examined monoclonal BLV proviral integration by inverse PCR in order to diagnose EBL.
However, the sensitivity and specificity of inverse PCR as diagnostic method of EBL are not
known. Further investigation is required to clear the usefulness of inverse-PCR method for
diagnosing EBL.BMP-6 is involved in fine tuning the balance between proliferation, apoptosis, and
differentiation in human B progenitor cells [21], and
is thought to play a role in the genesis and progression of many tumors. For instance,
methylation rates of the BMP-6 gene promoter region were increased in accordance with
disease progression in adult T-cell leukemia [41],
and concurrent repression of BMPs including BMP-6 by methylation was important in the onset
of lung cancer [23]. In the present study,
methylation rates of the BMP-6 gene promoter region in EBL cattle were significantly higher
than those in healthy cattle, and the methylation-dependent loss of BMP-6 gene expression at
the mRNA level was observed. This suggests that methylation rate exceeding 33% of the BMP-6
gene promoter region might cause BMP-6 gene transcriptional repression and contribute to EBL
onset.Factors known to be associated with methylation status include aging, diet, chronic
inflammation, and viral infection [2, 16, 19, 31, 36]. In the
present study, the methylation rates of BMP-6 gene promoter region in EBL beef cattle under
3 years old were significantly higher than those in EBL dairy cattle under 3 years old.
Moreover, methylation rates of the BMP-6 gene promoter region in healthy beef cattle under 3
years old were also significantly higher than those in healthy dairy cattle under 3 years
old. In Japan, dairy cattle are fed mainly on forage grasses, whereas almost all of the beef
cattle in fatting stage are given a lot concentrated feed that contain very little V.A
[27, 35].
Serum concentrations of V.A and total cholesterol of beef cattle in fatting stage were
approximately 30 IU/dl and 150 mg/dl, respectively [1]. Decreased V.A intake and hyperlipidemia cause and promote inflammatory diseases
[5, 13], and
beef cattle often develop V.A deficiency and inflammatory diseases [27]. Therefore, feed management practices for beef cattle might
contribute to methylation of the BMP-6 gene promoter region, potentially leading to early
EBL onset. However, it remains unclear which factors related to beef cattle affected the
methylation status of BMP-6 promoter region. Further investigation is required to clarify
the factors that caused hypermethylation of the BMP-6 gene promoter region. In 2 dairy EBL
cattle over 3 years old, methylation levels of the BMP-6 gene promoter region were
increased. The age of those cattle were 112 and 140 month-old (Supplementary Table 3). Although methylation status of BMP-6 promoter
region in those cattle might be influenced by age, cause of hypermethylation was unclear.
Methylation rates of the BMP-6 gene promoter region did not differ significantly between
BLV-positive healthy cattle and BLV-negative healthy cattle, suggesting that BLV infection
may not affect methylation rates of the BMP-6 gene promoter region in healthy cattle.Although higher methylation rates of the BMP-6 gene promoter region were observed in EBL
cattle compared to those in healthy cattle, median methylation rates of the BMP-6 gene
promoter region in EBL cattle were comparable to those observed in cattle with BMP-6 gene
expression. Low levels of random methylation within the CpG islands may trigger or promote
hypermethylation of the surrounding CpG sites [40].
Moreover, some gastric cancer cell lines tend to have scattered methylation within CpG
island, which leads to dense methylation [43].
Therefore, sparse methylation, even at levels that do not affect transcriptional activity,
may increase the risk for hypermethylation and onset of EBL.In the present study, samples were mainly lymph nodes and peripheral blood in EBL cattle
and healthy cattle, respectively. Methylation statuses might be different between blood and
lymph nodes. Additional studies on methylation status of BMP-6 promoter region in same
tissue samples were needed to eliminate sample bias. Moreover, in the present study,
multiple samples from same animals were able to collect in only few cattle. Further
investigation is required to clear the characteristics of methylation status of BMP-6
promoter region in each tissue and peripheral blood.In conclusion, the present study revealed that the BMP-6 gene promoter region
hypermethylation was more common in EBL cattle than in healthy cattle. Moreover, methylation
rates of the BMP-6 gene promoter region in EBL beef cattle under 3 years old were
significantly higher than those in EBL dairy cattle under 3 years old. This suggests that
hypermethylation of the BMP-6 gene promoter region might represent a factor contributing to
early EBL onset in beef cattle.
Authors: Christian Kersten; Guri Dosen; June H Myklebust; Einar A Sivertsen; Marit E Hystad; Erlend B Smeland; Edith Rian Journal: Exp Hematol Date: 2006-01 Impact factor: 3.084